(Q44756637)

English

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Pruthi RS

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Derksen JE

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Moore D

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

93

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

275-278

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Role of cyclooxygenases in angiogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04601.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2004.04601.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44756637&oldid=2037555749"